Cargando…

Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial

Multigene assays can provide insight into key biological processes and prognostic information to guide development and selection of adjuvant cancer therapy. We report a comprehensive genomic and transcriptomic analysis of tumor samples from 171 patients at high risk for recurrent renal cell carcinom...

Descripción completa

Detalles Bibliográficos
Autores principales: Motzer, Robert J., Martini, Jean-François, Mu, Xinmeng J., Staehler, Michael, George, Daniel J., Valota, Olga, Lin, Xun, Pandha, Hardev S., Ching, Keith A., Ravaud, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550765/
https://www.ncbi.nlm.nih.gov/pubmed/36216827
http://dx.doi.org/10.1038/s41467-022-33555-8